GlobeNewswire

Cisco Continues To Evolve Its Routing Portfolio for Mass-Scale Networking to Meet Carriers' Needs

Dela

Global Service Providers Rely on Cisco for Networking Innovation

PARIS, MPLS+SDN+NFV World Congress, April 09, 2018 (GLOBE NEWSWIRE) -- The explosive growth in IP traffic continues to create opportunities and challenges for service providers who are focused on delivering compelling services to retain and grow their customer base. Changing network traffic patterns show 35% of Internet traffic will be carried metro-to-metro in 20211, up from 22% in 2016, with more devices connected to the network. As a result, service providers are adjusting their network routing plans to distribute features further to the edge for improved performance.

Cisco is leading with innovation that allows carriers to transform their networks to deal with the explosion in traffic growth and change in traffic patterns led by mobile apps and connections, IoT, video, 5G and more. Cisco has responded with innovative hardware, software and security additions to its service provider routing platform to offer a mix of options for customers needing feature-rich platforms with higher density to support intense bandwidth demands.

Powered by Cisco IOS XR, the industry's most trusted network operating system, this expanded portfolio offers an abundance of features that help to simplify operations such as zero-touch deployment, advanced programmability and model-driven telemetry.

Routing hardware additions include:

  • Cisco NCS 500 Series: Featuring a unified, single operating system (Cisco IOS XR), it addresses converged wireline and wireless 5G-ready requirements for fronthaul, midhaul and backhaul, and future evolutions of carrier ethernet networks; It addresses various bandwidth needs ranging from 1 Gigabyte to 100 Gbps interfaces in small form factors.
  • Cisco ASR 9901:  Also featuring a unified, single operating system (Cisco IOS XR), it supports applications such as distributed provider edge, Internet peering, metro aggregation and broadband network gateway (BNG) in a space-optimized platform; It delivers 900 Gbps of throughput while also providing flexibility in terms of port speeds ranging from 1 to 100 Gbps with industry-leading MACsec encryption support across all ports.
  • Cisco NCS 5500 Series: New components include:
    • Two fixed chassis supporting 24 and 36 100GE ports
    • A 36 100GE ports line card targeted at high-density core, mobile backhaul and data center interconnect use cases; Offers flexible port configuration supporting 10G/25G/40G and 100G per port with enhanced scale capabilities (external TCAM)
    • A compact 2RU router targeted at high-density metro aggregation, mobile backhaul networks and long-haul connectivity use cases; Delivers maximum flexibility with the support of Modular Port Adapters (MPA) with options of different port types and MACsec encryption support.

Routing software additions include:

  • Segment Routing: Offers service providers more control over Internet traffic by delivering a unified transport fabric across aggregation, edge, core and data center network domains with unmatched simplicity, resiliency and scalability; With Segment Routing Flexible Algorithm, a new addition to the Cisco Segment Routing Traffic Engineering toolkit, service providers can:
    • Optimize the same physical network infrastructure along various dimensions such as low-latency, bandwidth or path disjointness.
    • Custom fit 5G network slices to specific applications
  • Ethernet VPN (EVPN): Cisco is now offering seamless integration with Virtual Private LAN Service (VPLS), helping service providers speed up migration from VPLS to EVPN as another method to provide Ethernet-based multipoint to multipoint communication over IP or MPLS networks; EVPN offers improved scalability, optimal forwarding and helps prevent traffic floods.

With more applications and devices connected to the network, security threats are significantly increasing. Cisco is securing the service provider network at three levels to help protect against current and future threats:

  • Hardware: Ensuring platform integrity while in transit from factories to customer premises
  • Software: Providing secure boot and integrity check to ensure the software that is installed is genuine and unmodified
  • Network: Offering MACsec hardware support to encrypt traffic between network nodes as well as scalable anti-DDoS

"Cisco continues to drive innovation in service provider routing to help our customers uplevel their architectures and be one step ahead in managing their network traffic demands," said Jonathan Davidson, senior vice president and general manager, Service Provider Networking, Cisco. "As the majority of our customers get ready for 5G, our unmatched portfolio of options offers intent-based networking practices to enable networks to self-heal without service interruptions."

"We needed a future-proof networking platform to support high-density 100G interfaces with optimized power consumption to deliver ultrabroadband connections," said Marco Arioli, senior manager of Network Engineering at Fastweb."With the Cisco NCS 5500 platform, we are getting the scale and power efficiency we were looking for and are reaping the benefits of a seamless and unified software fabric, powered by Cisco IOS XR to accelerate our time-to-market and streamline adoption of new services."

"We are building a widespread and efficient network to speed broadband adoption across Italy," said Domenico Angotti, head of Engineering at Open Fiber. "We are deploying Cisco NCS 5500 in our national Points of Presence to give us the performance and high-density of 100GE interfaces with lower power consumption, and a rich set of YANG data models that are essential to advanced network programmability."

"Shentel is evolving its network to support 100G interfaces to keep pace with the growth of Internet services and lay the foundation for 5G services," said Edward McKay, senior vice president, Wireline and Engineering, Shentel. "Cisco IOS XR and segment routing technology is helping to simplify our operations with an SDN architecture designed to support multi-path routing with extreme scale across our core networks."

Cisco is leading the disruption in the industry with its technology innovations in systems; silicon; software and security; and its unrivalled expertise in mass-scale networking, automation, optical, optics, cable access, video, and mobility. Combining these capabilities with Cisco's portfolio of go-to-market security, collaboration, IoT, and professional services, we enable service providers, media and web companies to reduce cost and complexity, help secure their networks, and grow revenue.

Supporting Resources

RSS Feed for Cisco:  http://newsroom.cisco.com/dlls/rss.html

About Cisco
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at newsroom.cisco.com and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.

Press Contact
Sara Cicero, Service Provider PR, Cisco, stutzes@cisco.com

____________________________

1 Cisco Visual Networking Index Forecast 2016-2021




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum